The Ministry of Health and Prevention (MoHAP) has decided to ban three brands of blood pressure tablets from the UAE market. The reason behind this decision is that the tablets contained carcinogenic properties.
Circulars were issued against the three brands of medicines by the UAE ministry as they suspected those medicines may cause cancer in the human body. The US-manufactured defibrillator was also instructed to be withdrawn from the market as it failed to provide electric current while using.
According to circular No. 3603 issued by Dr. Amin Hussein Al Amiri, the ministry’s assistant undersecretary for public health policy and licensing, it ordered to withdraw all supplies of the medicine Arbitense 50 and 100 mg manufactured by the Abu Dhabi based company Neopharma LLC.
Blood pressure tablet, Amopress 5mg was also legally prohibited after the reports revealed that it also contains carcinogenic ingredients.
The manufacturer of the tablets was requested to withdraw all the supplies of the mentioned tablets from the public sector as well as private sector while the pharmacies were instructed to return the medicines to the supplier.
Circular No. 3604 claims to withdraw blood pressure medicine Hetlosar 50 and 100mg, which was manufactured by the company Nexen Pharma.
Another such medicine is ZOLL LifeVest 400 which was manufactured by the US company Zoll, was also banned by the ministry.

Related Articles